Clinical Trial Update: Surgery and Reducing Ionizing Radiation of the Unknown Primary [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes evaluating surgical management with reduced ionizing radiation for unknown primary head and neck cancers, including HP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hpv-positive Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Head and Neck Squamous Cell Carcinoma, HPV Positive Oropharyngeal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING